Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Preparation of a recombinant canine c-reactive protein and its monoclonal antibody

A reactive protein and recombinant protein technology, applied in the field of canine inflammation early diagnosis and peptides, can solve the problems of poor specificity of monoclonal antibodies, hinder the preparation of monoclonal antibodies, low expression, etc., to improve detection sensitivity and ensure broad detection spectrum. , the effect of improving the expression level

Active Publication Date: 2021-03-26
杭州贤至生物科技有限公司
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

This method usually requires the preparation of monoclonal antibodies that can recognize canine C-reactive protein. The immunogen used in the preparation of conventional canine C-reactive protein monoclonal antibodies is a complete protein expressed by genetic engineering technology. It is difficult to express in E. coli and the expression level is extremely low, which makes it difficult to carry out subsequent purification work and seriously hinders the preparation of its monoclonal antibody
In addition, due to the homology of the amino acid sequence of the antigenic epitope, the monoclonal antibody prepared using the full-length sequence of canine C-reactive protein as the immunogen has poor specificity and high homology with proteins of other species, which leads to distortion of the detection results

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation of a recombinant canine c-reactive protein and its monoclonal antibody
  • Preparation of a recombinant canine c-reactive protein and its monoclonal antibody
  • Preparation of a recombinant canine c-reactive protein and its monoclonal antibody

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0017] Example 1: Canine C-reactive protein dominant epitope selection

[0018] Taking canine C-reactive protein as the target antigen, using the biological software DNAssist2.0 to analyze the hydrophilicity and antigenicity of its antigenic epitope sequence, select A dominant antigenic epitope (SEQ ID No: 3) and B dominant antigenic epitope (SEQ ID No: 3) ID No: 4). At the same time, the results of sequence comparison showed that the selected two dominant antigenic epitopes, A and B, had a broad spectrum and were common epitopes for all canine C-reactive protein; and the A and B epitopes had no obvious homology with other protein sequences, Only present in the canine C-reactive protein sequence.

Embodiment 2

[0019] Example 2: Synthesis of polypeptides containing dominant epitopes of canine C-reactive protein

[0020] In order to enhance the activation effect of the selected epitope on the mouse immune system and shorten the preparation time of monoclonal antibodies, two dominant epitope sequences of canine C-reactive protein A and B were chemically synthesized and connected in series, and cysteine ​​was connected at the end (synthesized by Nanjing GenScript Biotechnology Co., Ltd.) to obtain a polypeptide, the specific sequence of which is shown in SEQ ID No: 2 in the sequence table.

Embodiment 3

[0021] Embodiment 3: polypeptide coupling KLH protein

[0022] Dissolve 20 mg of SMCC in 2 ml of DMF (dimethylformamide), add 0.8 ml of KLH into a 25 ml round bottom flask, and add 1×PBS (pH 7.2) to make the final protein concentration 15 mg / ml. The dissolved SMCC solution was slowly added dropwise to the 120 mg KLH protein system, and the reaction was stirred at room temperature for 1 h. Dialyze with 1L 1×PBS (pH7.4) solution at 4°C for 6 hours to remove free SMCC. Pour the dialyzed KLH protein into a 50ml centrifuge tube to obtain a volume of 20ml. Take out 417ul KLH-SMCC solution and transfer it to a 5ml centrifuge tube. 3.0 mg of polypeptide was dissolved with 0.6 ml of 1×PBS (pH 7.2) solution. The sulfhydryl group in the polypeptide was detected with E1lman reagent, and the OD value was 0.18. The polypeptide solution was added dropwise into the KLH-SMCC tube, and mixed with a vertical mixer at room temperature for 4 hours. The OD value was 0.02 when detected by Ellman...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
Login to View More

Abstract

The invention belongs to the biotechnological field, and provides a polypeptide. The polypeptide includes two dominant antigen epitopes of the recombinant canine C-reactive protein (CRP). The polypeptide is coupled with the KLH protein for enhancing the immune effect. The invention provides a canine CRP recombinant protein. The canine CRP recombinant protein mainly includes the two dominant antigen epitopes. Specific to the aim of increasing the yield of the recombinant protein in a prokaryotic expression system, the recombinant protein amino acid sequence is converted into a corresponding nucleotide sequence by using an escherichia coli preferred codons, the nucleotide sequence is subjected to chemical synthesis, and the recombinant protein expression vector is built. The invention further relates to the preparation of the recombinant protein mono-clone antibody, the mono-clone antibody is prepared by antigen immunization, cell fusion and a plurality of screening, the mono-clone antibody is purified, the fluorescent microsphere is marked respectively, the best mono-clone pair determined through orthogonal experiment, the recombinant canine C-reactive protein can be applied to diagnosis of inflammation.

Description

technical field [0001] The invention belongs to the field of biotechnology and relates to a polypeptide, which is chemically synthesized and coupled to KLH protein. It also involves a recombinant protein, a nucleotide sequence encoding the recombinant protein, a plasmid vector containing the above-mentioned nucleotide sequence, transformation of a strain containing the above-mentioned plasmid vector, and preparation of a canine C-reactive protein monoclonal clone using the above-mentioned KLH coupling protein Antibody, use the above recombinant protein to screen canine C-reactive protein monoclonal antibody and apply it to the early diagnosis of canine inflammation. Background technique [0002] When the body is stimulated by trauma, infection, etc., there will be an acute phase reaction. The stimulated macrophages, fibroblasts, and endothelial cells will release some pro-inflammatory factors to promote the liver to synthesize some blood acute phase reaction proteins. Acute...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K14/47C12N15/12C12N15/70C12N1/21C07K16/18C12R1/19
CPCC07K14/4737C07K16/18C12N15/70C12N2800/22
Inventor 胡祥叶余铭恩项美华朱伟王璐刘清泉吴琼杉曹丹琴武戌青王立童
Owner 杭州贤至生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com